February 11, 2020
‘Impressed With Impact’ of Ketamine in Cancer Palliative Care BookmarkGeorge Lundberg, MD
Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Depression is, for obvious reasons, common in patients with advanced cancer. The old, inexpensive drug ketamine—already approved for medical use by the U.S. Food and Drug Administration (FDA)—seems rapidly effective, according to small studies.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.